Author Manuscript Published OnlineFirst on February 27, 2018; DOI: 10.1158/0008-5472.CAN-17-3677 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 1 Heterochromatin protein 1α mediates development and 2 aggressiveness of neuroendocrine prostate cancer 3 Authors: Xinpei Ci1,2, Jun Hao1,2, Xin Dong2, Stephen Y. Choi1,2, Hui Xue2, Rebecca Wu2, 4 Sifeng Qu1,2, Peter W. Gout2, Fang Zhang2, Anne M. Haegert1, Ladan Fazli1, Francesco 5 Crea3, Christopher J. Ong1, Amina Zoubeidi1, Housheng H. He4,5, Martin E. Gleave1, Colin C. 6 Collins1, Dong Lin1,2,*, Yuzhuo Wang1,2,* 7 Author affiliation: 1Vancouver Prostate Centre, Department of Urologic Sciences, 8 University of British Columbia, Vancouver, BC, Canada. 9 2Department of Experimental Therapeutics, BC Cancer, Vancouver, BC, Canada. 10 3School of Life, Health & Chemical Sciences, The Open University, Walton Hall, Milton 11 Keynes, MK7 6AA, United Kingdom. 12 4Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada. 13 5Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. 14 Running title: Heterochromatin gene signature unveils HP1α mediating NEPC 15 Key words: Neuroendocrine prostate cancer, HP1α, Transdifferentiation, PDX 16 Conflict of Interest: The authors have no conflicts of interest to disclose. 17 Word Count (Main text): 5069 18 Number of Figures: 6 19 * Corresponding author: 20 Yuzhuo Wang 21 Vancouver Prostate Centre 22 Department of Urologic Sciences, University of British Columbia 23 2660 Oak Street, Vancouver, 24 BC V6H 3Z6, Canada 25 Phone: 604-675-8013, email:
[email protected] 1 Downloaded from cancerres.aacrjournals.org on October 2, 2021.